In university students in Jordan, most people consume far less calcium from dairy than recommended, and those with the lowest intake are more likely to report trouble sleeping, feelings of depression, and body pain, indicating a possible link between calcium intake and these health problems.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether increasing dietary calcium intake from dairy consistently improves insomnia severity, depression symptoms, and musculoskeletal pain across diverse populations, accounting for confounders like sleep hygiene, physical activity, and vitamin D status.
A systematic review and meta-analysis of randomized controlled trials evaluating the effect of daily dairy calcium supplementation (≥1000 mg) versus placebo for at least 12 weeks on insomnia severity (ISI score), depression symptoms (HADS score), and musculoskeletal pain intensity (NRS 0–10) in young adults aged 18–25 with confirmed low baseline calcium intake (<800 mg/d), with standardized outcome measures and adjustment for BMI, smoking, and physical activity.
Whether increasing dairy calcium intake to 1000 mg/day directly reduces insomnia severity, depression scores, and musculoskeletal pain in young adults with low baseline intake.
A double-blind, placebo-controlled RCT of 300 university students aged 18–24 in Jordan with baseline dairy calcium intake <800 mg/day, randomized to receive 1000 mg/day of dairy-derived calcium (via fortified milk or supplements) or placebo for 16 weeks, with primary outcomes measured by ISI, HADS, and NRS pain scores at baseline and endpoint, controlling for sleep hygiene, physical activity, and vitamin D status.
Whether low dairy calcium intake over time prospectively predicts the development of insomnia, depression, or musculoskeletal pain in young adults.
A prospective cohort study following 1000 university students aged 18–22 in Jordan for 2 years, measuring dairy calcium intake quarterly and assessing insomnia (ISI), depression (HADS), and musculoskeletal pain (NRS) annually, adjusting for baseline mental health, sleep habits, physical activity, and socioeconomic factors.
Whether individuals with clinically significant insomnia or depression have a history of significantly lower dairy calcium intake compared to matched controls without these conditions.
A case-control study comparing dairy calcium intake over the prior 6 months in 200 university students with moderate-to-severe insomnia (ISI ≥15) and 200 matched controls (ISI ≤7), and similarly for depression (HADS ≥11 vs ≤7), using validated food frequency questionnaires and controlling for age, gender, BMI, and smoking.
Whether low dairy calcium intake and insomnia/depression symptoms co-occur in a population at a single point in time.
A cross-sectional survey of 1000 university students measuring dairy calcium intake via food diary and assessing insomnia (ISI), depression (HADS), and musculoskeletal pain (NRS) simultaneously, as performed in the current study.